Insitro vs MasterControl

Side-by-side comparison of AI visibility scores, market position, and capabilities

MasterControl leads in AI visibility (72 vs 34)
Insitro logo

Insitro

EmergingBiotechnology

ML Drug Discovery

Drug discovery company founded by Daphne Koller integrating ML with high-throughput biology; raised $400M+ to build proprietary biological datasets for predicting drug targets and clinical outcomes in neurology, metabolic, and oncology programs.

AI VisibilityBeta
Overall Score
D34
Category Rank
#183 of 198
AI Consensus
77%
Trend
stable
Per Platform
ChatGPT
34
Perplexity
39
Gemini
36

About

Insitro is a drug discovery company founded in 2018 by Daphne Koller, a pioneer in machine learning and computational biology, having raised over $400M to build an integrated ML and biology platform. The company generates large-scale biological datasets using automated laboratory systems and human induced pluripotent stem cell models of disease, then trains machine learning models on this data to predict drug targets, patient stratification, and clinical outcomes. Unlike companies that apply ML to existing datasets, Insitro builds proprietary biological datasets specifically designed to train predictive models for drug discovery. The platform is being applied to neurological diseases, metabolic disorders, and oncology with the goal of identifying drug candidates more likely to succeed in clinical trials. Insitro has established partnerships with major pharmaceutical companies including Gilead Sciences and Bristol Myers Squibb to co-develop drugs using the platform. The company represents a model for how ML can be deeply integrated into pharmaceutical R&D rather than applied as a surface-level analytical layer.

Full profile
MasterControl logo

MasterControl

LeaderLife Sciences & BioTech

Quality Management & Manufacturing Execution Software

MasterControl is the leading QMS and MES platform for regulated life sciences industries, serving 1,100+ companies with $200M revenue in 2025; valued at $1.3B after $150M from Sixth Street, acquired Qualer in Mar 2025.

AI VisibilityBeta
Overall Score
B72
Category Rank
#19 of 198
AI Consensus
75%
Trend
stable
Per Platform
ChatGPT
78
Perplexity
71
Gemini
74

About

MasterControl is a leading provider of quality management system (QMS) and manufacturing execution system (MES) software for regulated industries, with a primary focus on pharmaceuticals, medical devices, biotechnology, and food and beverage. The company's AI-powered platform digitizes and automates compliance-critical workflows including document control, training management, audit management, change control, corrective and preventive action (CAPA), risk management, and electronic batch records — replacing paper-based processes that are error-prone, audit-vulnerable, and incompatible with modern manufacturing velocity.

Full profile

AI Visibility Head-to-Head

34
Overall Score
72
#183
Category Rank
#19
77
AI Consensus
75
stable
Trend
stable
34
ChatGPT
78
39
Perplexity
71
36
Gemini
74
36
Claude
74
29
Grok
67

Key Details

Category
ML Drug Discovery
Quality Management & Manufacturing Execution Software
Tier
Emerging
Leader
Entity Type
brand
brand

Capabilities & Ecosystem

Capabilities

Only Insitro
ML Drug Discovery

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.